Olmesartán/Amlodipino/Hidroclorotiazida Stada

Olmesartan medoxil, the active ingredient in Olmesartán/Amlodipino/Hidroclorotiazida Stada, is a combination antihypertensive presented as a tablet for oral use. It treats high blood pressure in adults. GNH USA supplies Olmesartán/Amlodipino/Hidroclorotiazida Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Olmesartán/Amlodipino/Hidroclorotiazida Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Olmesartan medoxil/amlodipine/hydrochlorothiazide is used in the management of hypertension, a condition characterized by elevated arterial pressure.

- Essential hypertension: lowers systolic and diastolic blood pressure to reduce cardiovascular risk. - Hypertension with edema: provides vasodilation and diuresis to alleviate fluid retention. - Hypertension in diabetic patients: assists  as  part  of  multifactorial risk‑reduction  strategies. - Resistant  or  difficult  to  control  hypertension  :  adds  additional  mechanistic  coverage  when  monotherapy  insufficient  .

Side effects may occur with this antihypertensive combination.

Common Side Effects: - Headache  :  mild to  moderate  t  head  pain  often  trans  ient. - Peripheral  edema  :  swelling  of  the  ankles  or  feet  due  to  fluid  shift  . - Dizziness  :  light‑  headedness  especially  upon  standing  . - Flushing  :  warmth  and  redness  of  the  skin. - Fatigue  :  general  tiredness  or  lack  of  energy. - Increased urination  :  more  frequent  urine  output.

Serious or Rare Side Effects: - Severe hypotension  :  dangerously low blood pressure. - Acute kidney injury  :  rapid decline in renal function. - Hyperkalemia  :  elevated potassium levels. - Liver enzyme elevation  :  abnormal liver function tests. - Allergic reactions  :  rash, itching, swelling, or anaphylaxis. - Blood‑cell abnormalities  :  e.g., neutropenia or thrombocytopenia.

Patients  to  take  care  when  using  this  combination  product  because  of the  multiple  pharmacologic  effects  that  can  influence  cardiovascular  and  renal  function  .

- Monitor  blood  pressure  :  regular checks to ensure therapeutic targets are met. - Assess  renal  function  :  periodic serum creatinine and eGFR testing. - Check  electrolytes  :  especially potassium and sodium levels. - Review  concomitant  medications  :  avoid additive hypotensive agents. - Caution in  elderly  patients  :  dose may need adjustment. - Store at below 25°C: keep in the original pack , protect from moisture.

The combination            …  

Major  Inter­   S   …     …   e   g  ....  ....  ...  e  ....   e  d  d  …  \\\